Ryzumvi 0.75% Dilation Reversal Drop

SKU: RX-3159
PRICE
Login to view price
Need help or have questions? (813) 502-5869
Mon–Fri 9am–6pm EST

Description

RYZUMVI (Phentolamine Ophthalmic Solution) 0.75% is indicated for the treatment of pharmacologically-induced mydriasis produced by adrenergic agonists (e.g.phenylephrine) or parasympatholytic (e.g.tropicamide) agents. The only available FDA-approved treatment for the reversal of pharmacologically-induced mydriasis.

Specifications

Shipping methods and availability vary by product and destination. Contact MEDHealth Choice if you need help with expedited shipping, special-order items, or product availability.